SKSUY
Sekisui Chemical Co., Ltd. [SKSUY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SKSUY Stock Summary
In the News
SKSUY Financial details
Company Rating
Buy
Market Cap
6.01B
Income
74.89B
Revenue
1254.22B
Book val./share
1736.2
Cash/share
262.08
Dividend
-
Dividend %
-
Employees
26.84K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
62.13
Forward P/E
-
PEG
5.6
P/S
0.75
P/B
6.21
P/C
0.27
P/FCF
38.79
Quick Ratio
1.09
Current Ratio
1.97
Debt / Equity
0.14
LT Debt / Equity
0.11
-
-
EPS (TTM)
175.41
EPS next Y
-
EPS next Q
-
EPS this Y
91.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.35%
Revenue last 5Y
1.69%
Revenue Q/Q
-4.07%
EPS Q/Q
-31%
-
-
-
-
SMA20
2.2%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
6%
ROE
10%
ROC
0.1%
Gross Margin
31%
Oper. Margin
7%
Profit Margin
6%
Payout
34%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
69.85-78.45
52W High
-8.63%
52W Low
+3.29%
RSI
38.88
Rel Volume
1.24
Avg Volume
113
Volume
140
Perf Week
-2.66%
Perf Month
-0.43%
Perf Quarter
-
Perf Half Y
-5.26%
-
-
-
-
Beta
0.585
-
-
Volatility
1.62%, 1.36%
Prev Close
-5.36%
Price
71.27
Change
-5.84%
SKSUY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.45K | 2.46K | 2.34K | 2.6K | 2.86K | |
| Net income per share | 141.74 | 128.8 | 91.92 | 83.17 | 159.19 | |
| Operating cash flow per share | 182.74 | 201.63 | 166.54 | 235.64 | 164.43 | |
| Free cash flow per share | 40.79 | 77.08 | 29.21 | 135.54 | 34.79 | |
| Cash per share | 149.87 | 167.18 | 193.5 | 324.28 | 232.32 | |
| Book value per share | 1.3K | 1.33K | 1.48K | 1.51K | 1.62K | |
| Tangible book value per share | 1.25K | 1.15K | 1.32K | 1.47K | 1.57K | |
| Share holders equity per share | 1.3K | 1.33K | 1.48K | 1.51K | 1.62K | |
| Interest debt per share | 101.67 | 226.82 | 274.29 | 242.67 | 243.19 | |
| Market cap | 4376.26B | 2752.46B | 4665.85B | 4027.98B | 4048.18B | |
| Enterprise value | 4361.5B | 2795.4B | 4727.37B | 4016.79B | 4083.43B | |
| P/E ratio | 66.21 | 46.51 | 112.31 | 108.67 | 58.45 | |
| Price to sales ratio | 3.83 | 2.44 | 4.42 | 3.48 | 3.26 | |
| POCF ratio | 51.36 | 29.71 | 61.99 | 38.35 | 56.58 | |
| PFCF ratio | 230.09 | 77.71 | 353.37 | 66.68 | 267.45 | |
| P/B Ratio | 7.21 | 4.52 | 6.99 | 5.97 | 5.74 | |
| PTB ratio | 7.21 | 4.52 | 6.99 | 5.97 | 5.74 | |
| EV to sales | 3.82 | 2.48 | 4.47 | 3.47 | 3.29 | |
| Enterprise value over EBITDA | 31.76 | 20.98 | 40.53 | 29.2 | 28.74 | |
| EV to operating cash flow | 51.18 | 30.17 | 62.8 | 38.25 | 57.08 | |
| EV to free cash flow | 229.31 | 78.92 | 358.03 | 66.49 | 269.78 | |
| Earnings yield | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | |
| Free cash flow yield | 0 | 0.01 | 0 | 0.01 | 0 | |
| Debt to equity | 0.08 | 0.17 | 0.18 | 0.16 | 0.15 | |
| Debt to assets | 0.05 | 0.09 | 0.11 | 0.09 | 0.09 | |
| Net debt to EBITDA | -0.11 | 0.32 | 0.53 | -0.08 | 0.25 | |
| Current ratio | 1.51 | 1.47 | 1.79 | 1.85 | 1.9 | |
| Interest coverage | 199.35 | 126.58 | 78.17 | 114.83 | 105.24 | |
| Income quality | 1.29 | 1.57 | 1.81 | 2.83 | 1.03 | |
| Dividend Yield | 0 | 0.01 | 0 | 0.01 | 0.01 | |
| Payout ratio | 0.3 | 0.36 | 0.5 | 0.58 | 0.34 | |
| Sales general and administrative to revenue | 0.17 | 0.17 | 0.18 | 0.16 | 0.16 | |
| Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.05 | 0.09 | 0.08 | 0.04 | 0.04 | |
| Capex to operating cash flow | -0.78 | -0.62 | -0.82 | -0.42 | -0.79 | |
| Capex to revenue | -0.06 | -0.05 | -0.06 | -0.04 | -0.05 | |
| Capex to depreciation | -1.59 | -1.26 | -1.26 | -0.92 | -1.12 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.04K | 1.96K | 1.75K | 1.68K | 2.41K | |
| ROIC | 0.11 | 0.09 | 0.06 | 0.06 | 0.08 | |
| Return on tangible assets | 0.07 | 0.06 | 0.04 | 0.03 | 0.06 | |
| Graham Net | -178.53 | -338.38 | -287.07 | -203.43 | -246.76 | |
| Working capital | 158.86B | 157.67B | 223.29B | 279.7B | 293.67B | |
| Tangible asset value | 581.98B | 529.72B | 596.75B | 656.02B | 681.53B | |
| Net current asset value | 79.08B | 20.32B | 49.82B | 113.23B | 126.05B | |
| Invested capital | 0.08 | 0.17 | 0.18 | 0.16 | 0.15 | |
| Average receivables | 188.29B | 180.94B | 171.84B | 177.43B | 188.54B | |
| Average payables | 130.63B | 131.11B | 124.68B | 127.89B | 137.39B | |
| Average inventory | 183.07B | 205.66B | 220.05B | 233.37B | 265.32B | |
| Days sales outstanding | 59.95 | 56.31 | 58.54 | 58.44 | 56.31 | |
| Days payables outstanding | 60.49 | 61.63 | 57.94 | 61.8 | 56.65 | |
| Days of inventory on hand | 90.02 | 101.57 | 109.82 | 109.05 | 118.93 | |
| Receivables turnover | 6.09 | 6.48 | 6.23 | 6.25 | 6.48 | |
| Payables turnover | 6.03 | 5.92 | 6.3 | 5.91 | 6.44 | |
| Inventory turnover | 4.05 | 3.59 | 3.32 | 3.35 | 3.07 | |
| ROE | 0.11 | 0.1 | 0.06 | 0.05 | 0.1 | |
| Capex per share | -141.95 | -124.54 | -137.33 | -100.1 | -129.64 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 702 | 768.09 | 667.07 | 766.13 | 736.98 | |
| Net income per share | 31.59 | 38.28 | 56.4 | 47.77 | 32.96 | |
| Operating cash flow per share | -3.13 | 87.13 | 25.91 | 89.91 | 36.35 | |
| Free cash flow per share | -42.66 | 52.85 | -4.94 | 51.37 | -0.49 | |
| Cash per share | 218.27 | 235.06 | 237.01 | 324.91 | 262.08 | |
| Book value per share | 1.58K | 1.64K | 1.69K | 1.76K | 1.74K | |
| Tangible book value per share | 1.53K | 1.58K | 1.63K | 1.69K | 1.67K | |
| Share holders equity per share | 1.58K | 1.64K | 1.69K | 1.76K | 1.74K | |
| Interest debt per share | 268.8 | 244.68 | 244.36 | 245.28 | 244.76 | |
| Market cap | 3900.08B | 4000.9B | 4594.83B | 4795.57B | 4498.26B | |
| Enterprise value | 3951.79B | 4036.15B | 4631.37B | 4797.18B | 4507.75B | |
| P/E ratio | 71.16 | 60.76 | 47.61 | 59 | 80.43 | |
| Price to sales ratio | 12.81 | 12.11 | 16.1 | 14.71 | 14.39 | |
| POCF ratio | -2.87K | 106.78 | 414.43 | 125.38 | 291.73 | |
| PFCF ratio | -210.79 | 176.04 | -2.17K | 219.48 | -21.84K | |
| P/B Ratio | 5.7 | 5.67 | 6.36 | 6.42 | 6.11 | |
| PTB ratio | 5.7 | 5.67 | 6.36 | 6.42 | 6.11 | |
| EV to sales | 12.98 | 12.22 | 16.23 | 14.72 | 14.42 | |
| Enterprise value over EBITDA | 113.69 | 95.74 | 166.67 | 123.41 | 118.37 | |
| EV to operating cash flow | -2.91K | 107.73 | 417.73 | 125.43 | 292.35 | |
| EV to free cash flow | -213.59 | 177.59 | -2.19K | 219.55 | -21.88K | |
| Earnings yield | 0 | 0 | 0.01 | 0 | 0 | |
| Free cash flow yield | 0 | 0.01 | 0 | 0 | 0 | |
| Debt to equity | 0.17 | 0.15 | 0.14 | 0.14 | 0.14 | |
| Debt to assets | 0.1 | 0.09 | 0.08 | 0.08 | 0.08 | |
| Net debt to EBITDA | 1.49 | 0.84 | 1.31 | 0.04 | 0.25 | |
| Current ratio | 1.8 | 1.9 | 1.91 | 1.97 | 1.95 | |
| Interest coverage | 98.76 | 105.79 | 55.19 | 76.31 | 101.14 | |
| Income quality | -0.1 | 2.28 | 0.46 | 1.88 | 1.1 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.93 | 0 | 0.54 | 0 | 1.07 | |
| Sales general and administrative to revenue | 0 | 0.09 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | |
| Capex to operating cash flow | 12.62 | -0.39 | -1.19 | -0.43 | -1.01 | |
| Capex to revenue | -0.06 | -0.04 | -0.05 | -0.05 | -0.05 | |
| Capex to depreciation | -1.36 | -1.14 | -1.06 | -1.26 | -1.17 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.06K | 1.19K | 1.46K | 1.37K | 1.13K | |
| ROIC | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Return on tangible assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Graham Net | -298.02 | -249.67 | -227.18 | -133.44 | -178.35 | |
| Working capital | 273.54B | 293.67B | 299.73B | 327.05B | 315.03B | |
| Tangible asset value | 661.67B | 681.53B | 696.37B | 718.1B | 707.58B | |
| Net current asset value | 106.38B | 126.05B | 143.23B | 171.2B | 159.38B | |
| Invested capital | 0.17 | 0.15 | 0.14 | 0.14 | 0.14 | |
| Average receivables | 186B | 188.77B | 186.4B | 191.19B | 200.45B | |
| Average payables | 137.97B | 137.49B | 129.44B | 120.91B | 120.64B | |
| Average inventory | 280.45B | 287.81B | 295.63B | 300.31B | 299.25B | |
| Days sales outstanding | 54.94 | 52.23 | 57.12 | 55.58 | 57.48 | |
| Days payables outstanding | 59.18 | 53.48 | 55.64 | 47.74 | 51.49 | |
| Days of inventory on hand | 123.52 | 112.28 | 138.54 | 118.27 | 127.88 | |
| Receivables turnover | 1.64 | 1.72 | 1.58 | 1.62 | 1.57 | |
| Payables turnover | 1.52 | 1.68 | 1.62 | 1.89 | 1.75 | |
| Inventory turnover | 0.73 | 0.8 | 0.65 | 0.76 | 0.7 | |
| ROE | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | |
| Capex per share | -39.53 | -34.28 | -30.86 | -38.55 | -36.83 |
SKSUY Frequently Asked Questions
What is Sekisui Chemical Co., Ltd. stock symbol ?
Sekisui Chemical Co., Ltd. is a JP stock and trading under the symbol SKSUY
What is Sekisui Chemical Co., Ltd. stock quote today ?
Sekisui Chemical Co., Ltd. stock price is $71.27 today.
Is Sekisui Chemical Co., Ltd. stock public?
Yes, Sekisui Chemical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 113
- Market Capitalization 6.01B
- Employee 26.84K
- CEO Mr. Keita Kato
- Headquarters Osaka,JP
- IPO Date 2013-02-12
-
Website
https://www.sekisui.co.jp 
Sekisui Chemical Co., Ltd. engages in housing, urban infrastructure and environmental products (UIEP), high-performance plastics (HPP), and medical businesses. The Housing segment engages in the manufacturing, construction, sale, refurbishing, and other operations related to unit housing, real estate, and residential service business. The UIEP segment manufactures, constructs, and sells PVC pipes and joints, polyethylene pipes and joints, pipe and drain renewal materials and construction methods, reinforced plastic pipe, construction materials, and fiber-reinforced foamed urethane. The HPP segment engages in the manufacture and sale of interlayer films for laminated glass, polyolefin foam, tape, LCD fine particles and photosensitive materials, functional resin for infrastructure, diagnostic drugs, and other products. The Medical segment manufactures and sells diagnostic reagents, analyzers, pharmaceutical ingredients, and intermediates. It operates in Japan, the United States, Europe, Asia, and internationally. The company was formerly known as Sekisui Sangyo Co., Ltd. and changed its name to Sekisui Chemical Co., Ltd. in 1948. Sekisui Chemical Co., Ltd. was incorporated in 1947 and is headquartered in Osaka, Japan.
